Jeri Beltman

Evaluation of <i>in vitro</i> absorption, distribution, metabolism, and excretion and assessment of drug-drug interaction of rucaparib, an orally potent poly(ADP-ribose) polymerase inhibitor

Mingxiang Liao, Sarah Jaw‐Tsai, Jeri Beltman et al. · Xenobiotica · 2020 · 40 citations

Medicine, Pharmacokinetics, Pharmacology +17

Evaluation of absorption, distribution, metabolism, and excretion of [14C]-rucaparib, a poly(ADP-ribose) polymerase inhibitor, in patients with advanced solid tumors

Mingxiang Liao, Simon P. Watkins, Eileen Nash et al. · Investigational New Drugs · 2019 · 35 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17

Design and synthesis of selective keto-1,2,4-oxadiazole-based tryptase inhibitors

James T. Palmer, Robert M. Rydzewski, Rohan Mendonca et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 22 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Evaluation of Drug–Drug Interactions of Rucaparib and <scp>CYP</scp>1A2, <scp>CYP</scp>2C9, <scp>CYP</scp>2C19, <scp>CYP</scp>3A, and P‐gp Substrates in Patients With an Advanced Solid Tumor

Jim Xiao, Dorota Nowak, Rodryg Ramlau et al. · Clinical and Translational Science · 2018 · 21 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11

Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment

Nikolay Grechko, Viera Skarbová, Monika Tomaszewska‐Kiecana et al. · Cancer Chemotherapy and Pharmacology · 2021 · 17 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14